Reda Instrumente GmbH, headquartered in Tuttlingen, is an internationally active, medium-sized medical technology company. Since its founding in 1990, the company's core business has been trading high-quality surgical instruments and medical products. The product range includes instruments for general surgery, neurology, cardio, orthopedics, ENT, plastic surgery, urology, arthroscopy, laparoscopy and containers; it is complemented by specialized instruments, selected devices and accessory components. Reda supports customers worldwide in optimizing instrument logistics processes through modular sets, standardized product lines and digital catalog solutions and supplies hospitals, clinics, specialized dealers and international distribution partners.
der Handel mit chirurgischen Instrumenten. Die Gesellschaft darf sich auch auf branchenähnlichem Gebiet betätigen, in diesem Geschäftsbereich andere Unternehmen erwerben, sich an solchen beteiligen und alle Rechtsgeschäfte vornehmen, die im Interesse der Gesellschaft liegen. Die Gesellschaft ist berechtigt, Zweigniederlassungen im In- und Ausland zu errichten.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 450626 (as of 30 October 2026)
| Name | Type | City |
|---|---|---|
| Regina Hehl | Geschäftsführer(in) | Tuttlingen |
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 450626 (as of 30 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | Rohergebnis€10.2M2 | €5,304,991 | €19,328,911 | 36 |
| 2023 | Rohergebnis€10M2 | €5,175,513 | €17,061,981 | 33 |
| 2022 | ≤ €12M1 | — | €22,366,080 | 30 |
| 2021 | ≤ €12M1 | — | €18,373,746 | 24 |
| 2020 | ≤ €12M1 | — | €17,318,991 | 23 |
| 2019 | ≤ €12M1 | — | €17,512,081 | 29 |
| 2018 | ≤ €12M1 | — | €16,027,844 | 27 |
| 2017 | ≤ €12M1 | — | €15,324,035 | 29 |
| 2016 | ≤ €12M1 | — | €15,994,452 | 32 |
| 2015 | ≤ €12M1 | €901,178 | €14,540,650 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 450626 (as of 30 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €1,545,127 | 93.7% |
| Depreciation | €93,147 | 5.6% |
| Interest & Similar | €11,551 | 0.7% |
